{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:14:30Z","timestamp":1783386870069,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","award":["gzwkj2024\\u2013364"],"award-info":[{"award-number":["gzwkj2024\\u2013364"]}],"id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.psychres.2025.116908","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:11:26Z","timestamp":1765782686000},"page":"116908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of haloperidol-promethazine combination versus chlorpromazine-promethazine in managing acute behavioral disturbances and violent behavior in psychiatric patients"],"prefix":"10.1016","volume":"356","author":[{"given":"Jiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Jin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psychres.2025.116908_bib0001","first-page":"125","article-title":"Analysis of factors influencing violent behavior in patients with severe mental disorders who do not take medication in Shenzhen communities","volume":"54","author":"Peng","year":"2021","journal-title":"Chin. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116908_bib0002","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1192\/j.eurpsy.2020.63","article-title":"The prevalence of mental disorders and patterns of comorbidity within a large sample of mentally ill prisoners: a network analysis","volume":"63","author":"Van Buitenen","year":"2020","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116908_bib0003","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2147\/PRBM.S266976","article-title":"Ch'ng ML, Yoong MT. Prevalence and factors associated with suicidal ideation in institutionalized patients with schizophrenia","volume":"13","author":"Chong","year":"2020","journal-title":"Psychol. Res. Behav. Manag."},{"issue":"2","key":"10.1016\/j.psychres.2025.116908_bib0004","first-page":"12","article-title":"Clinical analysis of manic psychosis in patients with organ donation donor kidney transplantation after death","volume":"18","author":"Zhong","year":"2020","journal-title":"Int. J. Transplant. Blood Purif."},{"key":"10.1016\/j.psychres.2025.116908_bib0005","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2025"},{"key":"10.1016\/j.psychres.2025.116908_bib0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquillisation of violent or agitated patientsin a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v.haloperidol plus promethazine","volume":"185","author":"Alexander","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"7625","key":"10.1016\/j.psychres.2025.116908_bib0007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.39341.608519.BE","article-title":"Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine","volume":"335","author":"Raveendran","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116908_bib0008","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eurpsy.2019.01.014","article-title":"The pharmacological management of agitated and aggressive behaviour: a systematic review and meta-analysis","volume":"57","author":"Bak","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116908_bib0009","series-title":"Antipsychotic Drugs or Benzodiazepines for Rapid Tranquilization in Mental Health Facilities or Emergency Department Settings","author":"Brankston","year":"2021"},{"key":"10.1016\/j.psychres.2025.116908_bib0010","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.12688\/f1000research.19933.1","article-title":"Study protocol for a randomised controlled trial of haloperidol plus promethazine plus chlorpromazine versus haloperidol plus promethazine for rapid tranquilisation for agitated psychiatric patients in the emergency setting (TREC-Lebanon)","volume":"8","author":"Dib","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.psychres.2025.116908_bib0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/abr.abr_229_18","article-title":"Comparison of haloperidol, promethazine, trifluoperazine, and chlorpromazine in terms of velocity and durability of the sedation among acute aggressive patients: a randomized clinical trial","volume":"8","author":"Mousavi","year":"2019","journal-title":"Adv. Biomed. Res."},{"issue":"13","key":"10.1016\/j.psychres.2025.116908_bib0012","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1017\/S0033291720004869","article-title":"Rapid tranquillisation in a psychiatric emergency hospital in Lebanon: tREC-Lebanon - a pragmatic randomised controlled trial of intramuscular haloperidol and promethazine v. intramuscular haloperidol, promethazine and chlorpromazine","volume":"52","author":"Dib","year":"2022","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.psychres.2025.116908_bib0013","first-page":"14","article-title":"Clinical analysis of manic mental disorders after kidney transplantation from donation after cardiac death","volume":"21","author":"Zhong","year":"2020","journal-title":"Pract. Clin. Med."},{"key":"10.1016\/j.psychres.2025.116908_bib0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine","volume":"185","author":"Alexander","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116908_bib0015","series-title":"Antipsychotic Drugs or Benzodiazepines for Rapid Tranquilization in Mental Health Facilities or Emergency Department Settings","author":"Brankston","year":"2021"},{"key":"10.1016\/j.psychres.2025.116908_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/abr.abr_229_18","article-title":"Comparison of haloperidol, promethazine, trifluoperazine, and chlorpromazine in terms of velocity and durability of the sedation among acute aggressive patients: a randomized clinical trial","volume":"8","author":"Mousavi","year":"2019","journal-title":"Adv. Biomed. Res."},{"issue":"4","key":"10.1016\/j.psychres.2025.116908_bib0017","article-title":"Chlorpromazine for psychosis induced aggression or agitation","volume":"2010","author":"Ahmed","year":"2010","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125005530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125005530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:39:06Z","timestamp":1783384746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125005530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":17,"alternative-id":["S0165178125005530"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116908","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of haloperidol-promethazine combination versus chlorpromazine-promethazine in managing acute behavioral disturbances and violent behavior in psychiatric patients","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116908"}}